Roche Holding AG

Grenzacherstrasse 124
Basel, BASEL-STADT, 4058  Switzerland
+41-616881111
Company Type: Joint Stock Company Parent

D&B Business Directory

One of the world's largest pharmaceutical companies, Roche sells its products in over 100 countries. Roche's prescription drugs include cancer therapies MabThera/Rituxan and Avastin, Perjeta and Kadcyla for HER2-positive breast cancer, idiopathic pulmonary fibrosis drug Esbriet, macular degeneration therapy Lucentis, and Tamiflu, which is used for infectious diseases. The company markets many of its bestsellers through California-based subsidiary Genentech and Japanese affiliate Chugai Pharmaceutical. Roche's diagnostics arm offers clinical lab supplies, genetic tests, diabetes monitoring supplies, and point-of-care diagnostics for health care providers. Roche records among the world's highest pharmaceutical R&D spend annually and generates majority of sales from North America.

Try D&B Hoovers Free
Company Profile
Joint Stock Company Parent
Address
Grenzacherstrasse 124
Basel , BASEL-STADT, 4058  Switzerland
See other locations
Company Description

One of the world's largest pharmaceutical companies, Roche sells its products in over 100 countries. Roche's prescription drugs include cancer therapies MabThera/Rituxan and Avastin, Perjeta and Kadcyla for HER2-positive breast cancer, idiopathic pulmonary fibrosis drug Esbriet, macular degeneration therapy Lucentis, and Tamiflu, which is used for infectious diseases. The company markets many of its bestsellers through California-based subsidiary Genentech and Japanese affiliate Chugai Pharmaceutical. Roche's diagnostics arm offers clinical lab supplies, genetic tests, diabetes monitoring supplies, and point-of-care diagnostics for health care providers. Roche records among the world's highest pharmaceutical R&D spend annually and generates majority of sales from North America.

Key Principal
Severin Anton Schwan See more contacts
Industry
Business Services Sector Business services, nec Management investment, open-end Investors, nec
Incorporated
1995
For additional insights sign up for a D&B Hoovers free trial
Website
Phone
+41-616881111

Financial Statements

Financial data as of December 31, 2019 (12 month period) in USD

Annual Revenue2019
$61.94 billion USD
1 USD = 0.9923 CHF

Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.

Competitor Profiles

See detailed profiles for insights and prospects on this company's top competitors.

Company Snapshot

Essential information for a successful call

  •  EMPLOYEES (All Sites) 146
  • ASSETS (MIL USD) 83,738
  •  REVENUE (MIL USD) 61,944.76
  • TICKER SYMBOL ROG
  • Year Started 1896
  • Incorporated 1995
  • FISCAL YEAR END DEC
  • SALES GROWTH % 8.12%
  • NET INCOME GROWTH 28.54%

Get in Touch with 24 Principals*

A D&B Hoovers Subscription is your foot in the door to Roche Holding AG contact information.
  • Severin Anton Schwan
    Managing Director and Member of the Board of Directors and Authorised Signatory
  • Christoph Franz
    Chairman of the Board
  • Andreas Hoffmann
    Vice Chairman of the Board
  • Claudia Süssmuth
    Member of the Board of Directors

Want more contacts like these available directly in your inbox? Install D&B Email IQ to access your next prospects!

See full contact details

Start Your Free Trial

Related Products

Grow Business FasterLearn More
DNBiIntelligent Risk ManagementLearn More
Free Microsoft Outlook plugin to drive efficiency with on-demand sales intelligenceFree Install

Get full access to D&B Hoovers

With a Hoovers subscription you can get a comprehensive view of Roche Holding AG

Roche Holding AG*

24
Principals
See who the company's key decision makers are
594
Corporate Relations
Get the big picture on a company's affiliates and who they do business with.
9
Close Industry Peers
See similar companies for insight and prospecting.
*Contacts and Principals counts are estimates and may differ from the actual number of contacts available in D&B Hoovers.